Latest GUSTO data tips balance back to angioplasty
This article was originally published in Clinica
The final results of the GUSTO-2b(*) substudy, which compared primary angioplasty with thrombolysis in heart attack patients, now suggest that angioplasty is significantly better. The final results were presented at the European Society of Cardiology meeting in Birmingham by Dr Amadeo Betriu from the Provincial Hospital Clinica in Barcelona. Dr Betriu emphasised that the benefit is small, despite its statistical significance. The composite event rate for thrombolysis patients was 13.7% compared with 9.6% for primary angioplasty.
You may also be interested in...
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.
As a freshman member on the US House Energy and Commerce Committee, former St. Jude Medical exec Rep. Angie Craig can help shape future health care, cybersecurity bills.
The three names under consideration also have a history of focusing on helping underprivileged communities get access to health care.